CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Open-market sale CFO sold 35,000 shares at $26.50 ($927,500)
- 4 Open-market sale Chief Scientific Officer sold 19,467 shares at $14.70 ($286,165)
- 4 Open-market sale Director sold 8,750 shares at $15.95 ($139,594)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,404 shares at $11.84 ($28,463)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 4,747 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 4,274 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 36,826 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 10 of 30 · 592 filings